Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

More encouraging data for Spark and Pfizer’s potential haemophilia B cure

More encouraging data for Spark and Pfizer’s potential haemophilia B cure Here BioMarin looks to have the edge, with its valoctocogene roxaparvovec or ‘valrox’, formerly BMN 270 producing superior results to Spark’s own SPK-8011.

Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more

Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more and BioMarin’s haemophilia A gene therapy ‘valrox’..

NDA Group appoints Alison McGregor as its principal consultant

NDA Group appoints Alison McGregor as its principal consultant McGregor joins the group from BioMarin Pharmaceuticals, where she was previously global regulatory affairs leader.

Nektar Therapeutics appoints Jeff Ajer

Nektar Therapeutics appoints Jeff Ajer Ajer’s expertise includes driving commercial operations within rare diseases and speciality medicines and he joins the group from BioMarin, where he served as an executive vice president and chief commercial ... Prior to BioMarin, Ajer served as vice

Judge forces NHS England rethink on Kuvan

Judge forces NHS England rethink on Kuvan The health service claims the drug is not clinically effective. A judge has ordered NHS England to reconsider after refusing to fund treatment with Biomarin's Kuvan for a boy with ... BioMarin won EU approval in 2008 for Kuvan (sapropterin dihydrochloride

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics